Digestive enzyme cartridge
Customize your policy alerts
Sign up for AmeriHealth Caritas Policy CCP.1336 alerts
Get alerted when Policy CCP.1336 changes without checking for updates manually.
Monitor payer policy activity
Coverage and prior authorization for RELiZORB in adult and pediatric members, including neonates and infants, with confirmed exocrine pancreatic insufficiency receiving ongoing enteral nutrition and pancreatic enzyme replacement therapy. Other uses are investigational and reviewed case by case.
Coverage criteria were clarified to include adult and pediatric populations, including neonates and infants.
The evidence review incorporated two international clinical-practice guidelines and a multicenter retrospective study of children receiving enteral formula through an immobilized lipase cartridge.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.